{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "16724851", "DateCompleted": {"Year": "2006", "Month": "07", "Day": "13"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "69", "Issue": "5", "PubDate": {"Year": "2006", "Month": "May"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Weakly antimalarial flavonol arabinofuranosides from Calycolpus warszewiczianus.", "Pagination": {"StartPage": "826", "EndPage": "828", "MedlinePgn": "826-8"}, "Abstract": {"AbstractText": ["Three new flavonol arabinosides (2-4) were isolated from the young leaves of Calycolpus warszewiczianus. The structures were determined as myricetin-3-O-alpha-L-3' '-acetylarabinofuranoside (2), myricetin-3-O-alpha-L-3' ',5' '-diacetylarabinofuranoside (3), and 5-galloylquercetin-3-O-alpha-L-arabinofuranoside (4). Molecular structures were elucidated using NMR spectroscopy in combination with IR and MS data. Two known compounds, myricetin-3-O-alpha-L-arabinofuranoside (1) and (-)-epi-catechin (5), were also isolated. The compounds were tested in vitro against a chloroquine-resistant strain of Plasmodium falciparum, Leishmania mexicana, and Trypanosoma cruzi parasites. Compound 4 demonstrated weak activity against a chloroquine-resistant strain of P. falciparum (14.5 microM), whereas none of the compounds demonstrated activity against L. mexicana and T. cruzi at the concentrations of 40 and 50 microg/mL, respectively, and no cytotoxicity was detected against mammalian cells below 100 microg/mL."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Tropical Bioorganic Chemistry, Faculty of Natural, Exact Sciences and Technology, University of Panama, Panama City, Republic of Panama."}], "Identifier": [], "LastName": "Torres-Mendoza", "ForeName": "Daniel", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gonz\u00e1lez", "ForeName": "Jos\u00e9", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ortega-Barr\u00eda", "ForeName": "Eduardo", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Heller", "ForeName": "Mar\u00eda V", "Initials": "MV"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Capson", "ForeName": "Todd L", "Initials": "TL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "McPhail", "ForeName": "Kerry", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gerwick", "ForeName": "William H", "Initials": "WH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cubilla-Rios", "ForeName": "Luis", "Initials": "L"}], "GrantList": [{"GrantID": "1U01 TW-006634-01", "Acronym": "TW", "Agency": "FIC NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antimalarials"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiprotozoal Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonols"}, {"RegistryNumber": "886U3H6UFF", "NameOfSubstance": "Chloroquine"}, {"RegistryNumber": "B40ROO395Z", "NameOfSubstance": "Arabinose"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antimalarials"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antiprotozoal Agents"}, {"QualifierName": ["analogs & derivatives", "chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Arabinose"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Chloroquine"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Resistance"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Flavonols"}, {"QualifierName": ["drug effects"], "DescriptorName": "Leishmania mexicana"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Myrtaceae"}, {"QualifierName": [], "DescriptorName": "Panama"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Plasmodium falciparum"}, {"QualifierName": ["drug effects"], "DescriptorName": "Trypanosoma cruzi"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2006", "Month": "5", "Day": "27", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "7", "Day": "14", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "5", "Day": "27", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["16724851", "10.1021/np050484i"]}}], "PubmedBookArticle": []}